Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 48, 2008, Pages 18901-18906

  Inceoglu, Bora ^a   Jinks, Steven L ^b   Ulu, Arzu ^a   Hegedus, Christine M ^a   Georgi, Katrin ^a   Schmelzer, Kara R ^a   Wagner, Karen ^a   Jones, Paul D ^a   Morisseau, Christophe ^a   Hammock, Bruce D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cAMP; Inflammatory pain; Steroidogenesis

Indexed keywords

ARACHIDONIC ACID; CYCLIC AMP; CYTOCHROME P450; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; NEUROSTEROID; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COX2 GENE; FATTY ACID BLOOD LEVEL; GENE; GENE INDUCTION; INFLAMMATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STEROIDOGENESIS;

ANALGESICS; ANIMALS; CYCLIC AMP; CYCLOOXYGENASE 2; EICOSANOIDS; EPOXIDE HYDROLASES; GENE EXPRESSION REGULATION; MICE; PAIN MEASUREMENT; PHOSPHOPROTEINS; RATS; SIGNAL TRANSDUCTION;

EID: 57749091900     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0809765105     Document Type: Article

References (52)

1. Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120.
2. Capdevila JH, Falck JR, Estabrook RW (1992) Cytochrome P450 and the arachidonate cascade. FASEB J 6:731-736.
3. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349-361.
4. Ferreira SH, Lorenzetti BB, Correa FMA (1978) Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 53:39-48.
5. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235.
6. McGiff JC (1991) Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 31:339-369.
7. Spector AA, Norris AW (2006) Action of epoxyeicosatrienoic acids (EETs) on cellular function. Am J Physiol 292:C996-C1012.
8. Campbell W, Brady M, Rosolowsky L, Falck J (1991) Metabolism of arachidonic acid by rat adrenal glomerulosa cells: Synthesis of hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. Endocrinology 128:2183-2194.
9. Fisslthaler B, et al. (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401:493-497.
10. Campbell W, Gebremedhin D, Pratt PF, Harder DR (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78:415-423.
11. Node K, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285:1276-1279.
12. Terashvili M, et al. (2008) Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of β-endorphin and Met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther 326:614-622.
13. Inceoglu B, et al. (2006) Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci 79:2311-2319.
14. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, Hammock BD (2007) Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 82:42-49.
15. Schmelzer K, et al. (2005) Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA 102:9772-9777.
16. Jones PD, Tsai H-J, Do ZN, Morisseau C, Hammock BD (2006) Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett 16:5212-5216.
17. Ramwell PW, Shaw JE, Jessup R (1966) Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol 211:998-1004.
18. Malmberg AB, Yaksh TL (1992) Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257:1276-1279.
19. Samad TA, et al. (2001) Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-475.
20. Schmelzer K, et al. (2006) Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103:13646-13651.
21. Hay CH, de Belleroche JS (1998) Dexamethasone prevents the induction of COX-2 mRNA and prostaglandins in the lumbar spinal cord following i.pl. FCA in parallel with inhibition of oedema. Neuropharmacology 37:739-744.
22. Aley KO, Levine JD (2001) Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain 2:146-150.
23. Papadopoulos V, et al. (2006) Translocator protein (18 kDa): New nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402-409.
24. Papadopoulos V, et al. (1997) Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62:21-28.
25. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX (2006) Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138:749-756.
26. Papadopoulos V, Liu J, Culty M (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265- 266:59-64.
27. Bressana E, Fargesa RC, Ferrarab P, Tonussi CR (2003) Comparison of two PBR ligands with classical antiinflammatory drugs in LPS-induced arthritis in rats. Life Sci 72:2591-2601.
28. da Silva MB, Farges RC, Frode TS (2004) Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisy. Mediat Inflamm 13:93-103.
29. Van Voorhis BJ, et al. (1993) Metabolism of arachidonic acid to epoxyeicosatrienoic acids by human granulosa cells may mediate steroidogenesis. J Clin Endocrinol Metab 76:1555-1559.
30. Nishimura M, Hirai A, Omura M, Tamura Y, Yoshida S (1989) Arachidonic acid metabolites by cytochrome P-450 dependent monooxygenase pathway in bovine adrenal fasciculata cells. Prostaglandins 38:413-430.
31. Zosmer A, Elder MG, Sullivan MHF (2002) The production of progesterone and 5,6-epoxyeicosatrienoic acid by human granulosa cells. J Steroid Biochem Mol Biol 81:369-376.
32. Finn DA, et al. (2006) A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev 12:53-76.
33. Unger C, Eibl H, von Heyden HW, Kim DJ, Nagel GA (1986) Aminoglutethimide penetration of the blood brain barrier. Invest New Drugs 4:237-240.
34. Lin T (1985) Mechanism of action of gonadotropin-releasing hormone stimulated Leydig cell steroidogenesis III. The role of arachidonic acid and calcium/phospholipid dependent protein kinase. Life Sci 36:1255-1264.
35. Dix CJ, Habberfield AD, Sullivan MH, Cooke BA (1984) Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: Evidence for the involvement of lipoxygenase products in steroidogenesis. Biochem J 219:529-537.
36. Wang X, et al. (2006) The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression. J Endocrinol 190:871-878.
37. Clark BJ, Combs R, Hales KH, Hales DB, Stocco DM (1997) Inhibition of transcription affects synthesis of steroidogenic acute regulatory protein and steroidogenesis in MA-10 mouse Leydig tumor cells. Endocrinology 138:4893-4901.
38. Epstein LF, Orme-Johnson NR (1991) Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J Biol Chem 266:19739-19745.
39. Miller WL (2007) Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim Biophys Acta 1771:663-676.
40. Belelli D, Lambert JJ (2005) Neurosteroids: Endogenous regulators of the GABAA receptor. Nat Rev Neurosci 6:565-575.
41. Artemenko IP, Zhao D, Hales DB, Hales KH, Jefcoate CR (2001) Mitochondrial processing of newly synthesized steroidogenic acute regulatory protein (StAR), but not total StAR, mediates cholesterol transfer to cytochrome P450 side chain cleavage enzyme in adrenal cells. J Biol Chem 276:46583-46596.
42. Stocco DM, Wang X, Jo Y, Manna PR (2005) Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: More complicated than we thought. Mol Endocrinol 19:2647-2659.
43. Manna PR, Chandrala SP, Jo Y, Stocco DM (2006) cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation. J Mol Endocrinol 37:81-95.
44. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD (1989) Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 32:577-580.
45. Hucho T, Levine JD (2007) Signaling pathways in sensitization: Toward a nociceptor cell biology. Neuron 55:365-376.
46. Song X-J, Wang Z-B, Gan Q, Walters ET (2006) cAMP and cGMP contribute to sensory neuron hyperexcitability and hyperalgesia in rats with dorsal root ganglia compression. J Neurophysiol 95:479-492.
47. Wellmann W, Schwabe U (1973) Effects of prostaglandins E1, E2 and F2α on cyclic AMP levels in brain in vivo. Brain Res 59:371-378.
48. Taiwo YO, Levine JD (1991) Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44:131-135.
49. Poisbeau P, et al. (2005) Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production. J Neurosci 25:11768-11776.
50. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474.
51. Hohmann AG, et al. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435:1108-1112.
52. Lewis JW, Cannon JT, Liebeskind JC (1980) Opioid and nonopioid mechanisms of stress analgesia. Science 208:623-625.